A CONTROLLED TRIAL OF LEUPROLIDE WITH AND WITHOUT FLUTAMIDE IN PROSTATIC-CARCINOMA

被引:1304
作者
CRAWFORD, ED
EISENBERGER, MA
MCLEOD, DG
SPAULDING, JT
BENSON, R
DORR, FA
BLUMENSTEIN, BA
DAVIS, MA
GOODMAN, PJ
机构
[1] NCI, DIV CANC TREATMENT, CANC THERAPY EVALUAT PROGRAM, CLIN INVEST BRANCH, BETHESDA, MD 20205 USA
[2] SW ONCOL GRP, CTR STAT, SEATTLE, WA USA
[3] MAYO CLIN & MAYO GRAD SCH MED, DEPT UROL, N CENT CANC TREATMENT GRP, ROCHESTER, MN 55901 USA
[4] WALTER REED ARMY MED CTR, DEPT SURG, UROL SERV, WASHINGTON, DC 20307 USA
[5] UNIFORMED SERV UNIV HLTH SCI, NATL PROSTAT CANC PROJECT, BETHESDA, MD 20814 USA
[6] UNIV CALIF SAN FRANCISCO, DEPT UROL, NO CALIF ONCOL GRP, SAN FRANCISCO, CA 94143 USA
[7] FRED HUTCHINSON CANC RES CTR, SEATTLE, WA 98104 USA
[8] UNIV MARYLAND, DEPT MED, DIV MED ONCOL, BALTIMORE, MD 21201 USA
[9] UNIV MARYLAND, CTR CANC, MID ATLANTIC ONCOL PROGRAM, BALTIMORE, MD 21201 USA
关键词
D O I
10.1056/NEJM198908173210702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:419 / 424
页数:6
相关论文
共 35 条
[1]  
BRENDLER H, 1962, CANCER CHEMOTH REP, P323
[2]   A CONFIDENCE-INTERVAL FOR THE MEDIAN SURVIVAL-TIME [J].
BROOKMEYER, R ;
CROWLEY, J .
BIOMETRICS, 1982, 38 (01) :29-41
[3]  
BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO
[4]  
2-C
[5]  
COFFEY DS, 1981, UROLOGY, V17, P17
[6]  
Crawford E D, 1987, Prog Clin Biol Res, V243A, P283
[7]   THE ENDOCRINOLOGY AND DEVELOPMENTAL BIOLOGY OF THE PROSTATE [J].
CUNHA, GR ;
DONJACOUR, AA ;
COOKE, PS ;
MEE, S ;
BIGSBY, RM ;
HIGGINS, SJ ;
SUGIMURA, Y .
ENDOCRINE REVIEWS, 1987, 8 (03) :338-362
[8]  
DRAGO JR, 1984, CANCER-AM CANCER SOC, V53, P1447, DOI 10.1002/1097-0142(19840401)53:7<1447::AID-CNCR2820530703>3.0.CO
[9]  
2-G
[10]   A REEVALUATION OF NONHORMONAL CYTO-TOXIC CHEMOTHERAPY IN THE TREATMENT OF PROSTATIC-CARCINOMA [J].
EISENBERGER, MA ;
SIMON, R ;
ODWYER, PJ ;
WITTES, RE ;
FRIEDMAN, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) :827-841